Friday, July 20, 2018 1:03:28 PM
Can anyone effectively verify or dispute the info posted on Yahoo message board about some Zacks information concerning DMCAF being incorrect or incomplete that caused the recent selloff???
Recent DMAC News
- DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024 • Business Wire • 05/02/2024 12:55:00 PM
- DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke • Business Wire • 04/17/2024 08:08:00 PM
- DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results • Business Wire • 03/19/2024 08:15:00 PM
- DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference • Business Wire • 01/29/2024 09:13:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:23:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:12:31 PM
- DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer • Business Wire • 01/22/2024 01:23:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:47:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:39:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:30:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 09:37:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:55:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:52:34 PM
- DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results • Business Wire • 11/13/2023 09:28:00 PM
- DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023 • Business Wire • 11/09/2023 01:25:00 PM
- DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023 • Business Wire • 11/06/2023 01:23:00 PM
- DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer • Business Wire • 09/12/2023 12:13:00 PM
- DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference • Business Wire • 09/06/2023 12:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:15:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:29:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:25:12 PM
- DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results • Business Wire • 08/14/2023 08:13:00 PM
- DiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023 • Business Wire • 08/08/2023 12:32:00 PM
- DiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference • Business Wire • 07/18/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM